Literature DB >> 2703307

Investigation of the source of the blue field entoptic phenomenon.

S H Sinclair1, M Azar-Cavanagh, K A Soper, R F Tuma, H N Mayrovitz.   

Abstract

The cellular source of the blue field entoptic phenomenon was investigated in two microvascular preparations using video-microscopy with lighting conditions similar to those under which the entoptic phenomenon is visualized within the human eye. In the wing of the hibernating bat, microvascular flow was simultaneously videotaped under transmission illumination at 430 nm and under unfiltered illumination. In the rat cremaster alternating observations were made using transmission illumination at 430 nm and epi-illumination fluorescence microscopy with leukocytes rendered fluorescent by intravenous Quinacrine. In both preparations, low magnification video-microscopy using 430 nm illumination produced a field of particles, which were brighter than the background, flowing within a network of dark vessels. The appearance of the particles and their movement simulated the blue field entoptic particle motion. Under higher magnification, the particles appeared brighter than the plasma gaps between red blood cells and were demonstrated to be leukocytes by morphology, by specific staining and by typical behavioral movement. The particles were observed in terminal arteriols capillaries, and post-capillary venules where they were not obscured by red blood cells. The results of this study of two microvascular preparations strongly suggest that in the human eye the blue field entoptic phenomenon is produced by leukocytes flowing within the macular retinal microvasculature.

Entities:  

Mesh:

Year:  1989        PMID: 2703307

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

1.  Macular blood flow velocity in sickle cell disease: relation to red cell density.

Authors:  M S Roy; P Gascon; D Giuliani
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

2.  Scattering oblique plane microscopy for in-vivo blood cell imaging.

Authors:  Gregory N McKay; Ryan C Niemeier; Carlos Castro-González; Nicholas J Durr
Journal:  Biomed Opt Express       Date:  2021-04-05       Impact factor: 3.732

3.  Visualization of blood cell contrast in nailfold capillaries with high-speed reverse lens mobile phone microscopy.

Authors:  Gregory N McKay; Nela Mohan; Ian Butterworth; Aurélien Bourquard; Álvaro Sánchez-Ferro; Carlos Castro-González; Nicholas J Durr
Journal:  Biomed Opt Express       Date:  2020-03-30       Impact factor: 3.732

Review 4.  Ocular blood flow measurement.

Authors:  T H Williamson; A Harris
Journal:  Br J Ophthalmol       Date:  1994-12       Impact factor: 4.638

Review 5.  Visual snow--persistent positive visual phenomenon distinct from migraine aura.

Authors:  Christoph J Schankin; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2015-06

6.  Strict control of glycaemia: effects on blood flow in the large retinal vessels and in the macular microcirculation.

Authors:  J E Grunwald; C E Riva; B L Petrig; A J Brucker; S S Schwartz; S N Braunstein; J DuPont; S Grunwald
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

7.  Pulsatility of parafoveal capillary leukocytes.

Authors:  Joy A Martin; Austin Roorda
Journal:  Exp Eye Res       Date:  2008-07-30       Impact factor: 3.467

8.  Macular capillary particle velocities: a blue field and scanning laser comparison.

Authors:  O Arend; A Harris; W E Sponsel; A Remky; M Reim; S Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-04       Impact factor: 3.117

Review 9.  Visual Snow Syndrome: Proposed Criteria, Clinical Implications, and Pathophysiology.

Authors:  Abby I Metzler; Carrie E Robertson
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-22       Impact factor: 5.081

Review 10.  Visual snow syndrome, the spectrum of perceptual disorders, and migraine as a common risk factor: A narrative review.

Authors:  Antonia Klein; Christoph J Schankin
Journal:  Headache       Date:  2021-09-27       Impact factor: 5.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.